Stock of the Day

Today's Trend

Cinemark Holdings, Inc. (NYSE: CNK) is benefiting from strong second-quarter results, improving industry box-office trends and a bullish analyst upgrade. The stock is trading near its 52-week high as investors respond to the earnings beat and expectations for continued theatrical recovery.

• JPMorgan raised its price target from $35 to $40 and upgraded Cinemark to “overweight,” implying approximately 9% upside from the reference price. The upgrade provides additional support for the stock’s recent strength. Benzinga
• Cinemark reported second-quarter EPS of $1.19, well above Wall Street expectations of roughly $1.02-$1.03 and up from $0.63 a year earlier. Revenue reached $1.09 billion, exceeding the $1.03 billion consensus estimate and increasing 15.5% year over year. Cinemark Second Quarter Earnings Results
• The quarter was a company record, with more than 60 million moviegoers and the first time quarterly worldwide revenue surpassed $1 billion. Management attributed the performance to best-ever box-office results, premium offerings and stronger attendance. Cinemark Record-Breaking Second Quarter
• Cinemark reportedly gained market share during a strong box-office year, reinforcing the view that the broader theatrical exhibition recovery is translating into improved operating performance. Cinemark Market Share and Box Office Recovery
• Despite the earnings momentum, Cinemark remains highly leveraged, with a debt-to-equity ratio above 5, while its valuation has risen to roughly 32 times earnings. These factors could limit upside or increase sensitivity to any slowdown in attendance.